Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior.

Cortisol Hypothalamicpituitary- adrenal (HPA) axis. Inflammatory cytokines Kynurenine/tryptophan ratio Major depression Suicide

Journal

Current topics in medicinal chemistry
ISSN: 1873-4294
Titre abrégé: Curr Top Med Chem
Pays: United Arab Emirates
ID NLM: 101119673

Informations de publication

Date de publication:
2022
Historique:
received: 11 03 2021
revised: 04 07 2021
accepted: 24 07 2021
pubmed: 11 9 2021
medline: 16 12 2022
entrez: 10 9 2021
Statut: ppublish

Résumé

The increased degradation of tryptophan (Trp) along the kynurenine (Kyn) pathway due to inflammation and/or activation of the hypothalamic-pituitary-adrenal (HPA) axis has been reported among the biological factors involved in the pathophysiology of major depressive disorder (MDD) and suicide. However, the interaction among these multiple factors is not yet completely clarified. We studied plasma levels of Trp, Kyn, cortisol and proinflammatory cytokines (IL-1, IL- 6, IL-12, IL-20) and calculated the ratio Kyn/Trp as an index of the breakdown of Trp into Kyn in 31 suicidal MDD patients and 67 non-suicidal MDD patients. We confirmed that suicidal MDD patients have reduced plasma Trp, higher Kyn and Kyn/Trp ratio, and no difference in cortisol levels than non-suicidal MDD patients. IL-1 and IL-12 levels were significantly higher in suicidal MDD than in non-suicidal MDD (p=0.034 and p=0.023, respectively), whereas Il-6 and IL-20 levels were equal in the two groups. The Kyn/Trp ratio was positively correlated with a pro-inflammatory cytokines index (r=0.309, p=0.002) and cortisol (r=0.368, p=0.001). Notably, the variance in the Kyn/Trp ratio explained by the model including both cortisol and inflammatory parameters as dependent variables, substantially improved compared with the models in which the two parameters were considered separately. These findings show that both cortisol and proinflammatory cytokines are involved in the enhanced breakdown of Trp into Kyn occurring in suicidal MDD patients, thus adding new knowledge on the biological mechanisms leading to the activation of the Kyn pathway in MDD and suicide.

Sections du résumé

BACKGROUND BACKGROUND
The increased degradation of tryptophan (Trp) along the kynurenine (Kyn) pathway due to inflammation and/or activation of the hypothalamic-pituitary-adrenal (HPA) axis has been reported among the biological factors involved in the pathophysiology of major depressive disorder (MDD) and suicide. However, the interaction among these multiple factors is not yet completely clarified.
METHODS METHODS
We studied plasma levels of Trp, Kyn, cortisol and proinflammatory cytokines (IL-1, IL- 6, IL-12, IL-20) and calculated the ratio Kyn/Trp as an index of the breakdown of Trp into Kyn in 31 suicidal MDD patients and 67 non-suicidal MDD patients.
RESULT RESULTS
We confirmed that suicidal MDD patients have reduced plasma Trp, higher Kyn and Kyn/Trp ratio, and no difference in cortisol levels than non-suicidal MDD patients. IL-1 and IL-12 levels were significantly higher in suicidal MDD than in non-suicidal MDD (p=0.034 and p=0.023, respectively), whereas Il-6 and IL-20 levels were equal in the two groups. The Kyn/Trp ratio was positively correlated with a pro-inflammatory cytokines index (r=0.309, p=0.002) and cortisol (r=0.368, p=0.001). Notably, the variance in the Kyn/Trp ratio explained by the model including both cortisol and inflammatory parameters as dependent variables, substantially improved compared with the models in which the two parameters were considered separately.
CONCLUSION CONCLUSIONS
These findings show that both cortisol and proinflammatory cytokines are involved in the enhanced breakdown of Trp into Kyn occurring in suicidal MDD patients, thus adding new knowledge on the biological mechanisms leading to the activation of the Kyn pathway in MDD and suicide.

Identifiants

pubmed: 34503408
pii: CTMC-EPUB-117808
doi: 10.2174/1568026621666210909160210
doi:

Substances chimiques

Cytokines 0
Hydrocortisone WI4X0X7BPJ
Interleukin-1 0
Interleukin-12 187348-17-0
Kynurenine 343-65-7
Tryptophan 8DUH1N11BX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2119-2125

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Amel Messaoud (A)

Neuropsychopharmacology Unit, San Raffaele Scientific Institute and Vita-Salute University, Milan, Italy.
Department of Psychiatry, Monastir University Hospital, University of Monastir, Tunisia.

Mensi Rym (M)

Department of Psychiatry, Monastir University Hospital, University of Monastir, Tunisia.

Douki Wahiba (D)

Department of Psychiatry, Monastir University Hospital, University of Monastir, Tunisia.

Fadoua Neffati (F)

Biochemistry Department CHU Fattouma Bourguiba, Monastir, Tunisia.

Mohamed Fadhel Najjar (MF)

Biochemistry Department CHU Fattouma Bourguiba, Monastir, Tunisia.

Gabriella Gobbi (G)

Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University Health Center, McGill University, Montreal, QC, Canada.

Mirko Manchia (M)

Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada.

Flavia Valtorta (F)

Neuropsychopharmacology Unit, San Raffaele Scientific Institute and Vita-Salute University, Milan, Italy.

Gaha Lotfi (G)

Neuropsychopharmacology Unit, San Raffaele Scientific Institute and Vita-Salute University, Milan, Italy.

Stefano Comai (S)

Neuropsychopharmacology Unit, San Raffaele Scientific Institute and Vita-Salute University, Milan, Italy.
Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University Health Center, McGill University, Montreal, QC, Canada.
Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy.
Department of Biomedical Sciences, University of Padua, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH